For research teamsHelp me find a study
Back to all studies
CompletedNCT00277212

Aripiprazole for Bipolarity

This study is completed in the United States. It is testing aripiprazole for Bipolarity.

BipolarityDrugOver 18 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether the Safety and Efficacy of Aripiprazole may be useful for adults experiencing bipolarity.

What would participation involve?

Participants may receive the Safety and Efficacy of Aripiprazole, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with bipolarity.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2005
Recruitment status
Completed
Enrollment listed in the registry
1,169
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00277212
Official title
A Multicenter, Double-blind, Study of the Efficacy and Safety of Aripiprazole in Combination With Lamotrigine in the Long-term Maintenance Treatment of Patients With Bipolar I Disorder With a Recent Manic or Mixed Episode

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00277212. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Puerto Rico · 4 sites
  • Local Institution
    Cabo Rojo
    Site status: Not listed — confirm with the team
  • Local Institution
    Ponce
    Site status: Not listed — confirm with the team
  • Local Institution
    Rio Piedras
    Site status: Not listed — confirm with the team
  • Local Institution
    San Juan
    Site status: Not listed — confirm with the team
United States · 62 sites
  • University Of Alabama At Birmingham
    Birmingham, Alabama
    Site status: Not listed — confirm with the team
  • Southwest Biomedical Research Foundation
    Tucson, Arizona
    Site status: Not listed — confirm with the team
  • Pravin Kansagra, M.D.
    Anaheim, California
    Site status: Not listed — confirm with the team
  • College Hospital Costa Mesa
    Costa Mesa, California
    Site status: Not listed — confirm with the team
  • Pacific Institute For Medical Research, Inc.
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Excell Research
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Southern Ca Clinical Research, Inc.
    Pasadena, California
    Site status: Not listed — confirm with the team
  • Stanford University
    Stanford, California
    Site status: Not listed — confirm with the team
  • Los Angeles Biomedical Research Institute
    Torrance, California
    Site status: Not listed — confirm with the team
  • Pacific Clinical Research Medical Group
    Upland, California
    Site status: Not listed — confirm with the team
  • Health Sciences America, Llc
    Boca Raton, Florida
    Site status: Not listed — confirm with the team
  • Cns Clinical Research Group
    Coral Springs, Florida
    Site status: Not listed — confirm with the team
  • Act Clinical Research Institute, Llc
    Daytona Beach, Florida
    Site status: Not listed — confirm with the team
  • Neuropsychiatric Research Center Of Southwest Florida
    Fort Myers, Florida
    Site status: Not listed — confirm with the team
  • Aurora-Cuervo Clinical Trials
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Gulf Coast Medical Research
    Port Charlotte, Florida
    Site status: Not listed — confirm with the team
  • Janus Center For Psychiatric Research
    West Palm Beach, Florida
    Site status: Not listed — confirm with the team
  • Comprehensive Neuroscience, Inc
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Valle Vista Health System
    Greenwood, Indiana
    Site status: Not listed — confirm with the team
  • Clinco
    Terre Haute, Indiana
    Site status: Not listed — confirm with the team
  • Clinical Trials Technology, Inc
    Prairie Village, Kansas
    Site status: Not listed — confirm with the team
  • Clinical Research Institute
    Wichita, Kansas
    Site status: Not listed — confirm with the team
  • University Of Kentucky, Dept. Of Psychiatry
    Lexington, Kentucky
    Site status: Not listed — confirm with the team
  • Owensboro Behavioral Care
    Owensboro, Kentucky
    Site status: Not listed — confirm with the team
  • Sheppard Pratt Health System
    Baltimore, Maryland
    Site status: Not listed — confirm with the team
  • Clinical Insights
    Glen Burnie, Maryland
    Site status: Not listed — confirm with the team
  • Capital Clinical Research Associates
    Rockville, Maryland
    Site status: Not listed — confirm with the team
  • Psychopharmacology Research Corporation
    Farmington Hills, Michigan
    Site status: Not listed — confirm with the team
  • University Of Minnesota
    Minneapolis, Minnesota
    Site status: Not listed — confirm with the team
  • Regions Hospital
    Saint Paul, Minnesota
    Site status: Not listed — confirm with the team
  • Precise Research Centers
    Flowood, Mississippi
    Site status: Not listed — confirm with the team
  • University Of Medicine & Dentistry Of New Jersey
    Cherry Hill, New Jersey
    Site status: Not listed — confirm with the team
  • Buffalo Psychiatric Center
    Buffalo, New York
    Site status: Not listed — confirm with the team
  • Finger Lakes Clinical Research
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Richmond Behavioral Associates
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Duke University Medical Center
    Durham, North Carolina
    Site status: Not listed — confirm with the team
  • Zarzar Psychiatric Associates, Pllc
    Raleigh, North Carolina
    Site status: Not listed — confirm with the team
  • Horizon Medical Services
    Bismarck, North Dakota
    Site status: Not listed — confirm with the team
  • Neuro Behavioral Clinical Research, Inc.
    Canton, Ohio
    Site status: Not listed — confirm with the team
  • Community Research
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Saroj Brar Md, Inc
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • University Of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Cutting Edge Research
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Summit Research Network
    Portland, Oregon
    Site status: Not listed — confirm with the team
  • Lehigh Valley Hospital
    Allentown, Pennsylvania
    Site status: Not listed — confirm with the team
  • Lehigh Center For Clinical Research
    Allentown, Pennsylvania
    Site status: Not listed — confirm with the team
  • Dubois Regional Medical Center
    DuBois, Pennsylvania
    Site status: Not listed — confirm with the team
  • Freimer, Martin
    East Stroudsburg, Pennsylvania
    Site status: Not listed — confirm with the team
  • University Of Pennsylvania
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Belmont Center For Comprehensive Treatment
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Cns Research Institute
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Ut Medical Group/Odyssey Research
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Psychiatric Consultants, Pc
    Nashville, Tennessee
    Site status: Not listed — confirm with the team
  • Harmony Research, Llc
    Piney Flats, Tennessee
    Site status: Not listed — confirm with the team
  • Bayou City Research, Ltd.
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Alamo Superior Research
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • University Of Virginia Health System
    Charlottesville, Virginia
    Site status: Not listed — confirm with the team
  • Windwood Centre
    Virginia Beach, Virginia
    Site status: Not listed — confirm with the team
  • Pacific Institute Of Medical Sciences
    Bothell, Washington
    Site status: Not listed — confirm with the team
  • Summit Research Network (Seattle) Llc
    Seattle, Washington
    Site status: Not listed — confirm with the team
  • Health Research Center
    Morgantown, West Virginia
    Site status: Not listed — confirm with the team
  • Aurora Health Care
    Milwaukee, Wisconsin
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Lamotrigine + Aripiprazole, Lamotrigine + Placebo. Phase 4 studies usually happen after treatment approval, to monitor real-world use.

Who might this study be for?

This study may concern people with bipolarity; age range: Over 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., which appears to be a pharmaceutical company. Sponsor website: https://www.otsuka.co.jp/en/. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.